Capitol Health Limited (ASX:CAJ) Scheme Becomes Effective
Capitol Health announces the effective implementation of its acquisition by Integral Diagnostics, leading to trading suspension on the ASX.
Capitol Health announces the effective implementation of its acquisition by Integral Diagnostics, leading to trading suspension on the ASX.
LiveHire Ltd (ASX: LVH) recommended shareholders accept Humanforce’s unconditional takeover offer at $0.045 per share.
Titomic Limited announces the successful co-development and acceptance of a new cold spray standard with SAE International, enhancing its market position.
HealthCo Healthcare & Wellness REIT (HCW) announces property valuations increase and declares distribution for December 2024.
PainChek Limited (ASX:PCK) reports growth in implemented licenses and new government partnerships enhancing market opportunities.
Syntara Limited reports positive interim data from its Phase 2 trial of SNT-5505, indicating potential as a breakthrough treatment for myelofibrosis.
Positive interim data from Syntara Limited’s SNT-5505 trial in myelofibrosis indicates significant clinical potential.
OpenLearning Limited (ASX: OLL) has announced a voluntary suspension of its securities pending a key announcement regarding a related party loan facility.
Immutep Limited (ASX: IMM) has announced the initiation of TACTI-004, a Phase III trial for first-line metastatic non-small cell lung cancer.
Integral Diagnostics receives ACCC clearance for its merger with Capitol Health, expecting implementation by 20 December 2024.